Direktorat Registrasi ObatValid

GEMCITABINE

Claim this product
BPOM Number
GKL1943900144A1
Approved
21 November 2024
Expiry
26 February 2024
Form
SERBUK INJEKSI LIOFILISASI; 228 MG

About This Registration

GEMCITABINE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL1943900144A1. Its current registration status is Valid, with the licence valid until 26 February 2024. The product is registered to CKD OTTO PHARMACEUTICALS - INDONESIA. BPOM first approved this registration in February 2019. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application
Registrasi Obat
Packaging
DUS, 1 VIAL @ 200 MG
Department
Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available
Custom questionnaires
Professional shoppers
Detailed reporting
Starting from $50 per city
What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

Ingredients (1)

GEMCITABINE HYDROCHLORIDE

Market Intelligence

Owner Portfolio
CKD OTTO PHARMACEUTICALS - INDONESIA holds 49 BPOM registrations
Manufacturer Scale
CKD OTTO PHARMACEUTICALS - INDONESIA produces 49 registered products
Registration Age
Registered for 7 years, 6 months
Expiry Status
Expired 943 days ago

FDA Cross-Reference

via openFDA
Generic Name
GEMCITABINE HYDROCHLORIDE
Product Type
HUMAN PRESCRIPTION DRUG
Route of Administration
INTRAVENOUS

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?

Claim it to manage registration, track renewals, and get expiry alerts.

Claim Product
1